Unigestion Holding SA Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Unigestion Holding SA trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 55.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 17,015 shares of the healthcare conglomerate’s stock after selling 21,044 shares during the quarter. Unigestion Holding SA’s holdings in UnitedHealth Group were worth $8,607,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. M&T Bank Corp increased its position in shares of UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Signal Advisors Wealth LLC increased its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the period. Waycross Partners LLC boosted its stake in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Finally, Discipline Wealth Solutions LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $558,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $524.94 on Friday. The company has a market cap of $480.17 billion, a PE ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The business has a 50 day moving average of $509.24 and a 200 day moving average of $542.12. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on UNH shares. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.